| Literature DB >> 35812237 |
Walter Di Nardo1, Tiziana Di Cesare1, Angelo Tizio1, Gaetano Paludetti1, Anna Rita Fetoni2.
Abstract
Introduction: The cause of tinnitus improvement in cochlear implant (CI) users is not understood. On the basis that a spatially limited dysfunction in the auditory pathway could cause tinnitus, we used single-channel stimulation to evaluate any variation of tinnitus-perceived loudness and identify the cochlear regions involved. Materials andEntities:
Keywords: cochlear implant; cochlear regions; intracochlear electrical stimulation; pitch match; tinnitus
Year: 2022 PMID: 35812237 PMCID: PMC9263381 DOI: 10.3389/fnins.2022.885263
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 5.152
Patients’ demographic characteristics, causes, and duration of hearing loss (HL) and preoperative audiometric data.
| Patient | Sex | Age (yrs) | Hearing Loss (HL) cause | HL, duration (yrs) | PTA R (db) | PTA L (db) |
| N1 | Female | 53 | Ménière’s disease | 16 | 45 | 114 |
| N2 | Female | 65 | Otosclerosis | 43 | 68 | 120 |
| N3 | Male | 68 | Idiopathic | 18 | 120 | 99 |
| N4 | Male | 62 | Idiopathic | 53 | 84 | 103 |
| N5 | Female | 22 | Sudden HL | 10 | 102 | 99 |
| N6 | Male | 58 | Idiopathic | 58 | 115 | 115 |
| N7 | Female | 68 | Otosclerosis | 50 | 120 | 114 |
| N8 | Female | 58 | Cogan syndrome | 24 | 63 | 120 |
| N9 | Male | 53 | Otosclerosis | 30 | 102 | 102 |
| N10 | Female | 56 | Idiopathic | 13 | 120 | 120 |
| N11 | Male | 20 | CMV | 16 | 120 | 120 |
| N12 | Female | 59 | Iatrogenic (aminoglycosides) | 46 | 93 | 101 |
| N13 | Male | 55 | Auditory neuropathy | 13 | 67 | 77 |
| N14 | Female | 46 | Hereditary genetics | 10 | 62 | 72 |
| N15 | Male | 64 | Otosclerosis | 19 | 68 | 91 |
| N16 | Female | 47 | Idiopathic | 20 | 120 | 106 |
| N17 | Female | 38 | Idiopathic | 14 | 76 | 76 |
| N18 | Female | 63 | Otosclerosis | 30 | 91 | 112 |
| N19 | Female | 49 | Sudden HL | 30 | 84 | 93 |
| N20 | Female | 80 | Otosclerosis | 30 | 107 | 120 |
| N21 | Male | 40 | Otosclerosis | 10 | 99 | 75 |
PTA, pure tone average (average of hearing threshold levels at 500, 1,000, 2,000, and 4,000 Hz); R, right ear; L, left ear.
Detection of cochlear regions most involved in the attenuation/suppression of tinnitus: electrical channel with the greatest attenuation capacity on tinnitus in each patient [suppressive channel (SC)]; minimum current level suppressing tinnitus (MCLT) (μA).
| Patient | SC | Frequency | MCLT (μA) | CI model | Electrode length | Strategy of stimulation | Frequency of stimulation | Pulse width |
| N1 | 22 | 125–313 | 215,4 | Cochlear CI612 | 19mm | MP3000 | 900 | 25 |
| N2 | 7 | 3063–3563 | 244,4 | Cochlear CI512 | 19mm | MP3000 | 900 | 25 |
| N3 | Nf | / | / | Cochlear CI632 | 17mm | ACE | 900 | 25 |
| N4 | Nf | / | / | MED-EL Mi1200Flex28 | 28mm | FS4 | 1237 | 25.42–30.42 |
| N5 | 17 | 563–688 | 735,5 | Cochlear CI512 | 19mm | ACE | 900 | 25 |
| N6 | 4 | 491–710 | 368 | MED-EL Mi1200Flex28 | 28mm | FS4 | 1660 | 12.08–17.92 |
| N7 | 11 | 1813–2063 | 235,7 | Cochlear CI512 | 19mm | ACE | 900 | 25 |
| N8 | 22 | 125–313 | 344,5 | Cochlear CI24RE CA | 19mm | ACE | 900 | 25 |
| N9 | 22 | 125–313 | 613,9 | Cochlear CI512 | 19mm | ACE | 900 | 25 |
| N10 | 6 | 3563–4063 | 348,9 | Cochlear CI422 | 25mm | ACE | 900 | 25 |
| N11 | 22 | 125–313 | 204 | Cochlear CI512 | 19mm | ACE | 900 | 25 |
| N12 | 22 | 125–313 | 443,5 | Cochlear CI612 | 19mm | MP3000 | 900 | 25 |
| N13 | 11 | 1813–2063 | 215,4 | Cochlear CI512 | 19mm | ACE | 900 | 25 |
| N14 | Nf | / | / | AB Hires 90KJ | 20mm | HRes Optima-S | 1258 | 53 |
| N15 | Nf | / | / | Cochlear CI422 | 25mm | ACE | 900 | 25 |
| N16 | 22 | 125–313 | 560,9 | Cochlear CI24RE CA | 19mm | ACE | 900 | 25 |
| N17 | 1 | 100–198 | 397 | MED-EL Mi1200Flex28 | 28mm | FS4 | 1277 | 17.08–33.75 |
| N18 | 6 | 3563–4063 | 485,5 | Cochlear CI612 | 19mm | ACE | 900 | 25 |
| N19 | 19 | 563–688 | 309 | Cochlear CI612 | 19mm | ACE | 900 | 25 |
| N20 | Nf | / | / | Cochlear CI512 | 19mm | ACE | 900 | 25 |
| N21 | Nf | / | / | Cochlear CI512 | 19mm | ACE | 900 | 25 |
CI, cochlear implant model; nf, not found.
FIGURE 1The Visual Analog Scale (VAS) was used to assess tinnitus modification. Patients were asked to rate the perceived loudness of their tinnitus on a numeric scale, from 0 (inaudible) to 10 (loud like never before). L0, basal loudness of tinnitus (mean 6.4 ± 2.4); L1, minimal loudness of tinnitus at 10 s single-channel stimulation (mean 1.7 ± 2.7); L2, loudness of tinnitus after 30 min of whole CI activation (4.3 ± 2.5). Median values are displayed as a horizontal line, mean values as x, standard deviation as σ. We used t-test for statistical analysis. ∗∗p < 0.01, ∗p < 0.05.
FIGURE 2The Visual Analog Scale (VAS) was used to assess tinnitus modification. Patients were asked to rate the perceived loudness of their tinnitus on a numeric scale, from 0 (inaudible) to 10 (loud like never before), during short-term single-channel stimulation. The figure shows the cochlear regions involved in each patient. Only the frequency bands corresponding to the best-performer channels are depicted in the figure, not the entire cochlear tonotopy. L0, basal loudness of tinnitus; L1, loudness of tinnitus at 10 s single-channel stimulation; R, greatest percentage of tinnitus reduction.
Results of the pitch matching procedure.
| Patient | SC | Frequency band | Real pitch |
| N1 | 22 Cochlear | 188–313 Hz |
|
| N2 | 6 Cochlear | 3563–4063 Hz |
|
| N5 | 17 Cochlear | 813–938 Hz |
|
| N8 | 22 Cochlear | 188–313 Hz | 225 Hz |
| N13 | 11 Cochlear | 1813–2063 Hz | 2000 Hz |
| N17 | 1 MED-EL | 100–198Hz | 170 Hz |
| N19 | 19 Cochlear | 563–688 Hz | 625 Hz |
In three patients (N1, N2, N5), the actual pitch measured (bold values) did not fall 924 within the frequency range empirically assigned to the suppressive channel (SC).
FIGURE 3The Tinnitus Handicap Inventory (THI) trend in our sample: before surgery (mean 39.7 ± 27.2), 4 weeks after surgery (mean 40.3 ± 26.7), after 6 months (mean 27.8 ± 29.5) and after 1 year (mean 26.7 ± 28.9). Median values are displayed as a horizontal line, mean values as x, standard deviation as σ. We used t-test for statistical analysis. ∗p < 0.05.
Intergroup comparison.
| Patients | Polyphonic tinnitus | mean VAS (CI off – L0) | mean VAS (CI on – L2) | mean THI pre-op. | mean THI 1 year |
| Selective attenuation of tinnitus 15/21 | 0% | 6.6 | 4.5 | 40.6 | 30.5 |
| Non-selective attenuation of tinnitus 4/21 | 75% | 4.5 | 2.5 | 36.5 | 18.5 |
| No effect on tinnitus 2/21 | 100% | 8 | 6.5 | 72 | 40 |
*Statistically significant difference compared to patients with specific attenuation on tinnitus, p < 0.05.